These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation. Canetti C; Silva JS; Ferreira SH; Cunha FQ Br J Pharmacol; 2001 Dec; 134(8):1619-28. PubMed ID: 11739237 [TBL] [Abstract][Full Text] [Related]
46. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694 [TBL] [Abstract][Full Text] [Related]
47. Leukotriene B(4) enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes. Kanda N; Watanabe S Clin Exp Allergy; 2007 Jul; 37(7):1074-82. PubMed ID: 17581202 [TBL] [Abstract][Full Text] [Related]
48. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. Griffin JD; Spertini O; Ernst TJ; Belvin MP; Levine HB; Kanakura Y; Tedder TF J Immunol; 1990 Jul; 145(2):576-84. PubMed ID: 1694883 [TBL] [Abstract][Full Text] [Related]
49. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Ashcroft GS; Greenwell-Wild T; Horan MA; Wahl SM; Ferguson MW Am J Pathol; 1999 Oct; 155(4):1137-46. PubMed ID: 10514397 [TBL] [Abstract][Full Text] [Related]
50. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472 [TBL] [Abstract][Full Text] [Related]
51. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD. Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796 [TBL] [Abstract][Full Text] [Related]
52. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [TBL] [Abstract][Full Text] [Related]
53. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4. Wong E; Camp RD; Greaves MW J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362 [TBL] [Abstract][Full Text] [Related]
54. Leukotrienes and isocyanate-induced asthma: a pilot study. Lemiere C; Pelissier S; Tremblay C; Chaboillez S; Thivierge M; Stankova J; Rola-Pleszczynski M Clin Exp Allergy; 2004 Nov; 34(11):1684-9. PubMed ID: 15544591 [TBL] [Abstract][Full Text] [Related]
55. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin. Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071 [TBL] [Abstract][Full Text] [Related]
56. Flow cytometric determination of CD11b upregulation in vivo. Repo H; Jansson SE; Leirisalo-Repo M J Immunol Methods; 1993 Sep; 164(2):193-202. PubMed ID: 8370926 [TBL] [Abstract][Full Text] [Related]
57. The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol class. Sofia MJ; Floreancig P; Bach N; Baker SR; Nelson K; Sawyer JS; Baldwin R; Cockerham SL; Fleisch JH; Froelich LL; Jackson WT; Marder P; Roman CR; Saussy DL; Silbaugh SA; Spaethe SM; Stengel PW Adv Exp Med Biol; 1997; 400A():381-6. PubMed ID: 9547580 [No Abstract] [Full Text] [Related]
58. Leukotriene B4 triggers the in vitro and in vivo release of potent antimicrobial agents. Flamand L; Tremblay MJ; Borgeat P J Immunol; 2007 Jun; 178(12):8036-45. PubMed ID: 17548641 [TBL] [Abstract][Full Text] [Related]
59. Production of intraepidermal microabscesses by topical application of leukotriene B4. Camp R; Jones RR; Brain S; Woollard P; Greaves M J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504 [TBL] [Abstract][Full Text] [Related]
60. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry. Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]